UroGen’s urothelial cancer drug bags FDA approvalThe FDA has approved UroGen’s Jelmyto (mitomycin gel) as the first therapy to treat low-grade upper tract urothelial Share XUroGen’s urothelial cancer drug bags FDA approvalhttps://pharmaphorum.com/news/urogens-urothelial-cancer-drug-bags-fda-approval/
UroGen appoints former Novartis cancer chief Barrett as CEONovartis’ former oncology CEO Liz Barrett has left to join a little known biotech, UroGen, to help bring Share XUroGen appoints former Novartis cancer chief Barrett as CEOhttps://pharmaphorum.com/news/urogen-appoints-former-novartis-cancer-chief-barrett-as-ceo/
